Filing Details
- Accession Number:
- 0001415889-24-004624
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-21 16:31:41
- Reporting Period:
- 2024-02-16
- Accepted Time:
- 2024-02-21 16:31:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528115 | Annexon Inc. | ANNX | Pharmaceutical Preparations (2834) | 275414423 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1818522 | Michael Overdorf | C/O Annexon, Inc 1400 Sierra Point Pkwy, Bldg C, Ste 200 Brisbane CA 94005 | Evp & Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-16 | 39,000 | $0.00 | 87,592 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-02-20 | 1,951 | $5.48 | 85,641 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-02-16 | 160,000 | $0.00 | 160,000 | $5.13 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 160,000 | 2034-02-16 | No | 4 | A | Direct |
Footnotes
- Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 16 of each year, with the first 1/3rd vesting on February 16, 2025.
- The shares were sold to cover tax withholding obligations in connection with the vesting of RSUs.
- This transaction was executed in multiple trades in prices ranging from $5.34 to $5.60, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Billionaire Hedge Funds
